Characterization of Users of New Molecular Entities Approved in 2021 in TriNetX: An Updated Descriptive Analysis

Details

Basic Details

Date Posted

Thursday, May 30, 2024

Status

Complete

Medical Product

new molecular entities (NMEs)

Description

This analysis aimed to characterize users of 51 new molecular entities (NMEs) that were approved by the FDA in 2021 in the TriNetX Live™ platform. This query ran on February 13, 2024.

This report contains data from 59 health care organizations (HCOs), provided through the TriNetX Live™ platform in their USA Network with Minimal Shift from December 18, 2020 to December 31, 2023.

Deliverables (1)

Sentinel Modular Report: Characterization of Users of New Molecular Entities Approved in 2021 in TriNetX: An Updated Descriptive Analysis

Additional Information

Additional Details

FDA Center

CDER

Time Period

December 18, 2020 - December 31, 2023

Analysis Type

TriNetX Analysis

Population / Cohort

All Individuals

Data Sources

TriNetX USA Network